Cell Biotech Co Ltd 049960
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- KRW 11,990.00–12,420.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 12,370.00 / KRW 12,380.00
- Market Cap
- KRW 84.73 Bil
- Volume/Avg
- 78 / 34,263
Key Statistics
- Price/Earnings (Normalized)
- 11.73
- Price/Sales
- 1.53
- Dividend Yield (Trailing)
- 3.74%
- Dividend Yield (Forward)
- 3.74%
- Total Yield
- 3.74%
Company Profile
Cell Biotech Co Ltd is a specialized biotech company. It is engaged in the fermentation and coating technology development as well as manufacturing probiotics and lactic acid bacteria. The key product consists Probiotic DUOLAC, Nutra DUOLAC, LACTOClear, and LAB2PRO. The company distributes its products within domestic market and to overseas markets.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 133
- Website
- http://www.cellbiotech.com
Comparables
Valuation
|
Metric
|
049960
|
107590
|
085660
|
|---|---|---|---|
Price/Earnings (Normalized) | 11.73 | 12.09 | — |
Price/Book Value | 0.74 | 0.78 | 3.41 |
Price/Sales | 1.53 | 0.41 | 1.06 |
Price/Cash Flow | 8.00 | 9.12 | 36.24 |
Price/Earnings
049960
107590
085660
Financial Strength
|
Metric
|
049960
|
107590
|
085660
|
|---|---|---|---|
Quick Ratio | 15.78 | 0.65 | 0.73 |
Current Ratio | 16.99 | 1.23 | 0.83 |
Interest Coverage | 60.72 | 4.42 | 0.67 |
Quick Ratio
049960
107590
085660
Profitability
|
Metric
|
049960
|
107590
|
085660
|
|---|---|---|---|
Return on Assets (Normalized) | 6.38% | 3.42% | −0.51% |
Return on Equity (Normalized) | 6.81% | 7.38% | −2.90% |
Return on Invested Capital (Normalized) | 4.13% | 5.39% | 0.33% |
Return on Assets
049960
107590
085660
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Ssptkknf | Xcq | $559.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Brskgpvk | Rqnjrm | $103.9 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Hsmwqlxl | Hbyvrxn | $103.3 Bil | |
MRNA
| Moderna Inc | Jbccbdfxh | Pllvk | $42.7 Bil | |
ARGX
| argenx SE ADR | Jysjkcv | Wdb | $22.2 Bil | |
BNTX
| BioNTech SE ADR | Dpgnttkz | Vmgd | $21.7 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Srkmtzbp | Kvgrxs | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Nwqvgzkks | Qvmrbh | $15.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Wmwkwqqv | Xsnldp | $12.7 Bil | |
INCY
| Incyte Corp | Skwznwx | Jnqqvtr | $11.9 Bil |